These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14747791)

  • 21. Use of a dosimetry-based RAI protocol for treatment of benign hyperthyroidism optimises response while minimising exposure to ionising radiation.
    Miller C; Al-Jabri A; O'Murchada L; Mustafa M; Cooke J; Phelan N; Healy ML
    Clin Endocrinol (Oxf); 2024 Jun; 100(6):585-592. PubMed ID: 38567706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer.
    Hales IB; McElduff A; Crummer P; Clifton-Bligh P; Delbridge L; Hoschl R; Poole A; Reeve TS; Wilmshurst E; Wiseman J
    J Clin Endocrinol Metab; 1992 Sep; 75(3):886-9. PubMed ID: 1517381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.
    Giesecke P; Rosenqvist M; Frykman V; Friberg L; Wallin G; Höijer J; Lönn S; Törring O
    Thyroid; 2017 Jul; 27(7):878-885. PubMed ID: 28471268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease.
    Martin NM; Patel M; Nijher GM; Misra S; Murphy E; Meeran K
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):621-7. PubMed ID: 22443227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of radioiodine induced Graves' disease in patients with multinodular toxic goiter.
    Meller J; Siefker U; Hamann A; Hüfner M
    Exp Clin Endocrinol Diabetes; 2006 May; 114(5):235-9. PubMed ID: 16804797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperthyroidism and thyroid cancer.
    Edmonds CJ; Tellez M
    Clin Endocrinol (Oxf); 1988 Feb; 28(2):253-9. PubMed ID: 3168308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study.
    Carlé A; Knudsen N; Pedersen IB; Perrild H; Ovesen L; Rasmussen LB; Laurberg P
    Eur J Endocrinol; 2013 Nov; 169(5):537-45. PubMed ID: 23935127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age and stress as determinants of the severity of hyperthyroidism caused by Graves' disease in newly diagnosed patients.
    Vos XG; Smit N; Endert E; Brosschot JF; Tijssen JG; Wiersinga WM
    Eur J Endocrinol; 2009 Feb; 160(2):193-9. PubMed ID: 18974230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of hyperglycemic hyperosmolar state associated with Graves' hyperthyroidism: a case report.
    Moon SW; Hahm JR; Lee GW; Kang MY; Jung JH; Jung TS; Lee KW; Jung KA; Ahn YJ; Kim S; Kim MA; Kim DR; Chung SI; Park MH
    J Korean Med Sci; 2006 Aug; 21(4):765-7. PubMed ID: 16891829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter.
    Gedik O; Ozdemir T; Akalin S
    Isr J Med Sci; 1991 Jul; 27(7):361-4. PubMed ID: 1712765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperthyroidism due to Graves' disease and due to autonomous goiter.
    Schicha H; Emrich D; Schreivogel I
    J Endocrinol Invest; 1985 Oct; 8(5):399-407. PubMed ID: 3841136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease.
    Amino N; Tanizawa O; Mori H; Iwatani Y; Yamada T; Kurachi K; Kumahara Y; Miyai K
    J Clin Endocrinol Metab; 1982 Jul; 55(1):108-12. PubMed ID: 6896207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA antigens in Greek patients with thyrotoxicosis (Graves' disease and toxic nodular goiter).
    Papasteriades C; Alevizaki-Harhalaki MN; Economidou J; Ikkos DG
    J Endocrinol Invest; 1984 Aug; 7(4):283-6. PubMed ID: 6594386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the association of NIDDM in Japanese patients with hyperthyroid Graves' disease.
    Komiya I; Takasu N; Yamada T; Ohara N; Ootsuka H; Ota M; Fukushima H; Sekikawa A; Tominaga M; Sasaki H
    Horm Res; 1992; 38(5-6):264-8. PubMed ID: 1307749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
    Molnár I; Bokk A
    Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.